Impact of left ventricular remodelling patterns on outcomes in patients with aortic stenosis

Romain Capoulade1, Marie-Annick Clavel1, Florent Le Ven1

  • 1Institut Universitaire de Cardiologie et de Pneumologie de Québec/Québec Heart & Lung Institute, Laval University, 2725 Chemin Sainte-Foy, Québec City, QC, Canada G1V-4G5.

Insights

Concentric hypertrophy (CH) in patients with aortic stenosis (AS) and preserved ejection fraction is linked to increased mortality risk. This association is particularly significant in women, highlighting the need for tailored risk stratification.

Area of Science:

  • Cardiology
  • Cardiovascular Imaging
  • Clinical Outcomes

Background:

  • Aortic stenosis (AS) is a significant cause of cardiovascular morbidity and mortality.
  • Left ventricular (LV) remodelling patterns can influence prognosis in AS patients.
  • The prognostic value of different LV remodelling patterns in AS with preserved ejection fraction requires further investigation.

Purpose of the Study:

  • To investigate the association between distinct left ventricular (LV) remodelling and hypertrophy patterns and all-cause and cardiovascular mortality in patients with aortic stenosis (AS).
  • To determine if LV remodelling patterns stratify mortality risk in AS patients with preserved ejection fraction.

Main Methods:

  • Retrospective analysis of 747 consecutive AS patients with preserved LV ejection fraction.
  • Classification of patients into four LV patterns: normal, concentric remodelling (CR), concentric hypertrophy (CH), and eccentric hypertrophy (EH) based on LV mass index and relative wall thickness.
  • Median follow-up of 6.4 years to assess all-cause and cardiovascular mortality.

Main Results:

  • Concentric hypertrophy (CH) was identified in 53% of patients.
  • CH was significantly associated with a higher risk of all-cause mortality compared to other LV patterns (P < 0.05).
  • After multivariable adjustment, CH remained an independent predictor of mortality (HR=1.27).
  • A significant interaction between sex and CH was observed, with CH associated with worse outcomes in women (HR=1.56) but not in men.

Conclusions:

  • Concentric hypertrophy (CH) is an independent predictor of increased mortality in aortic stenosis (AS) patients with preserved ejection fraction.
  • The adverse prognostic impact of CH is more pronounced in women than in men.
  • Integrating LV remodelling patterns into risk stratification strategies for AS patients is recommended.
Abstract

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
528
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.0K
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
987
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
729
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.2K
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
802